Mucosal Healing Predicts the Long-Term Prognosis of Intestinal Behçet’s Disease

[1]  J. Cheon,et al.  The Medical Treatments of Intestinal Behçet's Disease: An Update , 2013 .

[2]  M. Neurath,et al.  Mucosal healing in inflammatory bowel diseases: a systematic review , 2012, Gut.

[3]  P. Rutgeerts,et al.  Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. , 2012, Gastroenterology.

[4]  E. Kuipers,et al.  Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation , 2011, Inflammatory bowel diseases.

[5]  P. Rutgeerts,et al.  Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. , 2011, Gastroenterology.

[6]  Young Sook Park,et al.  Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet's disease , 2011, Inflammatory bowel diseases.

[7]  M. Allez,et al.  Role of endoscopy in predicting the disease course in inflammatory bowel disease. , 2010, World journal of gastroenterology.

[8]  P. Rutgeerts,et al.  Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.

[9]  P. Rutgeerts,et al.  Mucosal healing and anti TNFs in IBD. , 2010, Current drug targets.

[10]  L. Peyrin-Biroulet,et al.  Clinical implications of mucosal healing for the management of IBD , 2010, Nature Reviews Gastroenterology &Hepatology.

[11]  Philippe Marteau,et al.  Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease , 2009, Inflammatory bowel diseases.

[12]  Eun Soo Kim,et al.  Development and Validation of Novel Diagnostic Criteria for Intestinal Behçet's Disease in Korean Patients With Ileocolonic Ulcers , 2009, The American Journal of Gastroenterology.

[13]  P. Rutgeerts,et al.  Mucosal healing predicts long‐term outcome of maintenance therapy with infliximab in Crohn's disease , 2009, Inflammatory bowel diseases.

[14]  K. Petraki,et al.  Azathioprine Is Superior to Budesonide in Achieving and Maintaining Mucosal Healing and Histologic Remission in Steroid‐Dependent Crohn's Disease , 2009, Inflammatory bowel diseases.

[15]  E. Ebert.  Gastrointestinal Manifestations of Behçet’s Disease , 2009, Digestive Diseases and Sciences.

[16]  J. Cheon,et al.  Recent advances of endoscopy in inflammatory bowel diseases. , 2007, Gut and liver.

[17]  Philippe Marteau,et al.  A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. , 2007, Gastroenterology.

[18]  A. Moss,et al.  Infliximab for induction and maintenance therapy for ulcerative colitis. , 2006, Gastroenterology.

[19]  M. Bala,et al.  Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease , 2006 .

[20]  G. Porro,et al.  A rare cause of diuretic refractory ascites , 2005, Gut.

[21]  Y. Cho,et al.  Colonoscopic Findings in Intestinal Behçet's Disease , 2001, Inflammatory bowel diseases.

[22]  I. Choi,et al.  Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. , 2000, Endoscopy.

[23]  D. V. van Thiel,et al.  Gastrointestinal manifestations of Behcet's disease. , 2000, Journal of clinical gastroenterology.

[24]  O. Ozcebe,et al.  Behçet's disease. , 2019, The New England journal of medicine.

[25]  P. Rutgeerts,et al.  Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. , 1999, Gastrointestinal endoscopy.

[26]  Shigeru Tanaka,et al.  Intestinal involvement in Behçet's disease: Review of 136 surgical cases in the Japanese literature , 1981, Diseases of the colon and rectum.

[27]  D. James.  Behcet's syndrome. , 1979, The New England journal of medicine.

[28]  M. Maruta,et al.  Intestinal Behçet's disease: Report of five cases , 1976, Diseases of the colon and rectum.